Nancy Retzlaff, chief commercial officer for Turing Pharmaceuticals LLC, appears before a House Oversight and Government Reform hearing on "Developments in the Prescription Drug Market Oversight" on Capitol Hill in Washington February 4, 2016. REUTERS/Joshua Roberts

News, Photo and Web Search